Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2008

01.10.2008

Modern noninvasive risk stratification in primary prevention of sudden cardiac death

verfasst von: J. Kreuz, L. M. Lickfett, J. O. Schwab

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective

Since the publication of MADIT II and SCD-HeFT, an implantable cardioverter defibrillator (ICD) for primary prevention represents an established, guideline-implemented therapeutic strategy. Facing such an enormous amount of potential ICD recipients, the identification of an effective risk stratification remains crucial.

Methods

This article reviews the tools of noninvasive risk stratification which are currently used and defines an optimal test configuration. This analysis focuses on the capacity of the tests regarding to the negative predictive value to reduce unneeded devices.

Results

Presently, no marker exists in terms of risk stratification which qualifies itself as gold standard. However, encouraging results can be stated for microvolt T-wave alternans (mTWA) providing a high negative predictive value. An increased QT variability (QTv) and an impaired deceleration capacity are associated with an excellent positive predictive value. Currently, only mTWA and QTv seem to be suitable in ischemic and non-ischemic disease, but available data, especially in non-ischemic patients, are too small to provide clear recommendations.

Conclusion

The most hopeful tools at hand in modern noninvasive risk evaluation of sudden cardiac death in primary prevention seem to be mTWA and QTv. These noninvasive methods provide the best negative predictive or positive predictive value of all known parameters, while a higher rate of complete coronary revascularizations in acute coronary syndromes might also reduce the number of fatal arrhythmic events and therefore complicate the invention of an ideal risk marker.
Literatur
1.
Zurück zum Zitat Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346, 877–883.PubMedCrossRef Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346, 877–883.PubMedCrossRef
2.
Zurück zum Zitat Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. New England Journal of Medicine, 352, 225–237.PubMedCrossRef Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. New England Journal of Medicine, 352, 225–237.PubMedCrossRef
3.
Zurück zum Zitat European Heart Rhythm Association; Heart Rhythm Society; Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J. J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.; American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Journal of the American College of Cardiology, 48, e247–346.PubMedCrossRef European Heart Rhythm Association; Heart Rhythm Society; Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J. J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.; American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Journal of the American College of Cardiology, 48, e247–346.PubMedCrossRef
4.
Zurück zum Zitat Kreuz, J., Balta, O., Liliegren, N., Mellert, F., Esmailzadeh, B., Nickenig, G., et al. (2007). Incidence and characteristics of appropriate and inappropriate therapies in recipients of ICD implanted for primary prevention of sudden cardiac death. PACE, 30, S125–S127.PubMed Kreuz, J., Balta, O., Liliegren, N., Mellert, F., Esmailzadeh, B., Nickenig, G., et al. (2007). Incidence and characteristics of appropriate and inappropriate therapies in recipients of ICD implanted for primary prevention of sudden cardiac death. PACE, 30, S125–S127.PubMed
5.
Zurück zum Zitat Kamphuis, H. C., de Leeuw, J. R., Derksen, R., Hauer, R. N., & Winnubst, J. A. (2003). Implantable cardioverter defibrillator recipients: Quality of life in recipients with and without ICD shock delivery: a prospective study. Europace, 5, 381–389.PubMedCrossRef Kamphuis, H. C., de Leeuw, J. R., Derksen, R., Hauer, R. N., & Winnubst, J. A. (2003). Implantable cardioverter defibrillator recipients: Quality of life in recipients with and without ICD shock delivery: a prospective study. Europace, 5, 381–389.PubMedCrossRef
6.
Zurück zum Zitat Connolly, S. J., Dorian, P., Roberts, R. S., Gent, M., Bailin, S., Fain, E. S., et al. (2006). Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study: A randomized trial. JAMA, 295, 165–171.PubMedCrossRef Connolly, S. J., Dorian, P., Roberts, R. S., Gent, M., Bailin, S., Fain, E. S., et al. (2006). Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study: A randomized trial. JAMA, 295, 165–171.PubMedCrossRef
7.
Zurück zum Zitat Wilkoff, B. L., Ousdigian, K. T., Sterns, L. D., Wang, Z. J., Wilson, R. D., & Morgan, J. M. (2006). A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: Results from the prospective randomized multicenter EMPIRIC trial. Journal of the American College of Cardiology, 48, 330–339.PubMedCrossRef Wilkoff, B. L., Ousdigian, K. T., Sterns, L. D., Wang, Z. J., Wilson, R. D., & Morgan, J. M. (2006). A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: Results from the prospective randomized multicenter EMPIRIC trial. Journal of the American College of Cardiology, 48, 330–339.PubMedCrossRef
8.
Zurück zum Zitat Ghuran, A., Reid, F., La Rovere, M. T., Schmidt, G., Bigger Jr., J. T., Camm, A. J., et al. (2002). Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction Substudy). American Journal of Cardiology, 89, 184–190.PubMedCrossRef Ghuran, A., Reid, F., La Rovere, M. T., Schmidt, G., Bigger Jr., J. T., Camm, A. J., et al. (2002). Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction Substudy). American Journal of Cardiology, 89, 184–190.PubMedCrossRef
9.
Zurück zum Zitat Berkowitsch, A., Zareba, W., Neumann, T., Erdogan, A., Nitt, S. M., Moss, A. J., et al. (2004). Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and limitations of a 10-minute Holter recording. Annals of Noninvasive Electrocardiology, 9, 270–279.PubMedCrossRef Berkowitsch, A., Zareba, W., Neumann, T., Erdogan, A., Nitt, S. M., Moss, A. J., et al. (2004). Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and limitations of a 10-minute Holter recording. Annals of Noninvasive Electrocardiology, 9, 270–279.PubMedCrossRef
10.
Zurück zum Zitat Bauer, A., Kantelhardt, J. W., Barthel, P., Schneider, R., Mäkikallio, T., Ulm, K., et al. (2006). Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: Cohort study. Lancet, 367, 1674–1681.PubMedCrossRef Bauer, A., Kantelhardt, J. W., Barthel, P., Schneider, R., Mäkikallio, T., Ulm, K., et al. (2006). Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: Cohort study. Lancet, 367, 1674–1681.PubMedCrossRef
11.
Zurück zum Zitat Malik, M., Camm, A. J., Janse, M. J., Julian, D. G., Frangin, G. A., & Schwartz, P. J. (2000). Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: A substudy of EMIAT. Journal of the American College of Cardiology, 35, 1263–1275.PubMedCrossRef Malik, M., Camm, A. J., Janse, M. J., Julian, D. G., Frangin, G. A., & Schwartz, P. J. (2000). Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: A substudy of EMIAT. Journal of the American College of Cardiology, 35, 1263–1275.PubMedCrossRef
12.
Zurück zum Zitat La Rovere, M. T., Pinna, G. D., Hohnloser, S. H., Marcus, F. I., Mortara, A., Nohara, R., et al. (2001). Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials. Circulation, 103, 2072–2077.PubMed La Rovere, M. T., Pinna, G. D., Hohnloser, S. H., Marcus, F. I., Mortara, A., Nohara, R., et al. (2001). Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials. Circulation, 103, 2072–2077.PubMed
13.
Zurück zum Zitat Couderc, J. P., Zareba, W., McNitt, S., Maison-Blanche, P., & Moss, A. J. (2007). Repolarization variability in the risk stratification of MADIT II patients. Europace, 9, 717–723.PubMedCrossRef Couderc, J. P., Zareba, W., McNitt, S., Maison-Blanche, P., & Moss, A. J. (2007). Repolarization variability in the risk stratification of MADIT II patients. Europace, 9, 717–723.PubMedCrossRef
14.
Zurück zum Zitat Hohnloser, S. H., Ikeda, T., Bloomfield, D. M., Dabbous, O. H., & Cohen, R. J. (2003). T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet, 362, 125–126.PubMedCrossRef Hohnloser, S. H., Ikeda, T., Bloomfield, D. M., Dabbous, O. H., & Cohen, R. J. (2003). T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet, 362, 125–126.PubMedCrossRef
15.
Zurück zum Zitat Bloomfield, D. M., Steinman, R. C., Namerow, P. B., Parides, M., Davidenko, J., Kaufman, E. S., et al. (2004). Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation, 110, 1885–1889.PubMedCrossRef Bloomfield, D. M., Steinman, R. C., Namerow, P. B., Parides, M., Davidenko, J., Kaufman, E. S., et al. (2004). Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation, 110, 1885–1889.PubMedCrossRef
16.
Zurück zum Zitat Salerno-Uriarte, J. A., De Ferrari, G. M., Klersy, C., Pedretti, R. F., Tritto, M., Sallusti, L., et al. (2007). Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: Results of the ALPHA Study. Journal of the American College of Cardiology, 50, 1896–904.PubMedCrossRef Salerno-Uriarte, J. A., De Ferrari, G. M., Klersy, C., Pedretti, R. F., Tritto, M., Sallusti, L., et al. (2007). Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: Results of the ALPHA Study. Journal of the American College of Cardiology, 50, 1896–904.PubMedCrossRef
17.
Zurück zum Zitat Haigney, M. C., Zareba, W., Gentlesk, P. J., Goldstein, R. E., Illovsky, M., McNitt, S., et al. (2004). QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Journal of the American College of Cardiology, 44, 1481–1487.PubMedCrossRef Haigney, M. C., Zareba, W., Gentlesk, P. J., Goldstein, R. E., Illovsky, M., McNitt, S., et al. (2004). QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Journal of the American College of Cardiology, 44, 1481–1487.PubMedCrossRef
18.
Zurück zum Zitat Bonnemeier, H., Hartmann, F., Wiegand, U. K. H., Bode, F., Katus, H. A., & Richardt, G. (2001). Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction. Journal of the American College of Cardiology, 37, 44–50.PubMedCrossRef Bonnemeier, H., Hartmann, F., Wiegand, U. K. H., Bode, F., Katus, H. A., & Richardt, G. (2001). Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction. Journal of the American College of Cardiology, 37, 44–50.PubMedCrossRef
19.
Zurück zum Zitat Chevalier, P., Burri, H., Adeleine, P., Kirkorian, G., Lopez, M., Leizorovicz, A., et al. (2003). QT dynamicity and sudden death after myocardial infarction: Results of a long-term follow-up study. Journal of Cardiovascular Electrophysiology, 14, 227–233.PubMed Chevalier, P., Burri, H., Adeleine, P., Kirkorian, G., Lopez, M., Leizorovicz, A., et al. (2003). QT dynamicity and sudden death after myocardial infarction: Results of a long-term follow-up study. Journal of Cardiovascular Electrophysiology, 14, 227–233.PubMed
20.
Zurück zum Zitat Iacoviello, M., Forleo, C., Guida, P., Romito, R., Sorgente, A., Sorrentino, S., et al. (2007). Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology, 50, 225–231.PubMedCrossRef Iacoviello, M., Forleo, C., Guida, P., Romito, R., Sorgente, A., Sorrentino, S., et al. (2007). Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology, 50, 225–231.PubMedCrossRef
21.
Zurück zum Zitat Elgarhi, N., Kreuz, J., Balta, O., Nickenig, G., Hoium, H., Lewalter, T., et al. (2008). Significance of Wedensky modulation testing in the evaluation of non-invasive risk stratification for ventricular tachyarrhythmia in patients with coronary artery disease and implantable cardioverter defibrillator. Heart, 94, e16.PubMedCrossRef Elgarhi, N., Kreuz, J., Balta, O., Nickenig, G., Hoium, H., Lewalter, T., et al. (2008). Significance of Wedensky modulation testing in the evaluation of non-invasive risk stratification for ventricular tachyarrhythmia in patients with coronary artery disease and implantable cardioverter defibrillator. Heart, 94, e16.PubMedCrossRef
Metadaten
Titel
Modern noninvasive risk stratification in primary prevention of sudden cardiac death
verfasst von
J. Kreuz
L. M. Lickfett
J. O. Schwab
Publikationsdatum
01.10.2008
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2008
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-008-9264-8

Weitere Artikel der Ausgabe 1/2008

Journal of Interventional Cardiac Electrophysiology 1/2008 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.